NCT06940375 - Prevelence of Liver Disease-Related Outcomes in People With HIV | Biotech Hunter

Enrollment

320

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

July 1, 2026

Conditions

MAFLDLiver FibrosisMASHHIVMetabolic Syndrome XHepatic Steatosis

Interventions

OTHER

Abdominal ultrasound , Fibroscan and body composition analysis examination

Abdominal ultrasound and Fibroscan examinations were conducted to obtain LSM, CAP, and calculate the FAST score. Bioelectrical impedance analysis was performed to obtain the content of subcutaneous and visceral fat.

Trial Locations (2)

201508

NOT_YET_RECRUITING

Shanghai Public Health Clinical Center, Shanghai

RECRUITING

Shanghai Public Health Clinical Center, Shanghai

All Listed Sponsors

lead

Shanghai Public Health Clinical Center

OTHER_GOV